Abstract
Tumors with ocogenic Ras protein expression are hard to cure, since they are able to restore viability after treatment with antitumor agents by activating cytoprotective processes. The search for new targets for more effective therapy has shown that mitochondria can serve as such a target, since Ras-expressing cells receive ATP primarily through oxidative phosphorylation, rather than glycolysis, like many other types of tumor cells. The study investigated the death of tumor cells expressing oncogenic Ras after X-ray irradiation in comparison with inhibitor of mitochondrial integrity ABT199 inhibitor (venetoclax) of mitochondrial integrity. It was shown that cells show different response in time to the action of damaging agents. In the early stages (2–24 h after of treatment), autophagy is activated, which eliminates damaged mitochondria and increases cell viability, while the appearance of senescent cells after 72 h is part of a late response that suppresses proliferation. Inhibition of autophagy and senescence increases cell death under the action of damaging agents, which indicates that these processes play a key role in inhibition of cell death after mitochondrial damage. Thus, inhibition of autophagy and senescence can increase the efficiency of tumor cell elimination by antitumor agents.
Similar content being viewed by others
REFERENCES
Altman, J.K., Szilard, A., Goussetis, D.J., Sassano, A., Colamonici, M., Gounaris, E., Frankfurt, O., Giles, F.J., Eklund, E.A., Beauchamp, E.M., and Platanias, L.C., Autophagy is a survival mechanism of acute myelogenous leukemia precursors during dual mTORC2/mTORC1 targeting, Clin. Cancer Res., 2014, vol. 20, p. 2400.
Amaravadi, R.K., Yu, D., Lum, J.J., Bui, T., Christophorou, M.A., Evan, G.I., Thomas-Tikhonenko, A., and Thompson, C.B., Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma, J. Clin. Invest., 2007, vol. 117, p. 326.
Blagosklonny, M.V., Cell cycle arrest is not senescence, Aging (Albany, N.Y.), 2011a, vol. 3, p. 94.
Blagosklonny, M.V., Molecular damage in cancer: an argument for mTOR-driven aging, Aging (Albany, N.Y.), 2011b, vol. 3, p. 1130.
Blagosklonny, M.V., Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging, Aging (Albany, N.Y.), 2012, vol. 4, p. 159.
Campisi, J., Cellular senescence: putting the paradoxes in perspective, Curr. Opin. Genet. Dev., 2011, vol. 21, p. 107.
Choudhary, G.S., Al-Harbi, S., Mazumder, S., Hill, B.T., Smith, M.R., Bodo, J., His, E.D., and Almasan, A., MCL‑1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies, Cell Death Dis., 2015, vol. 6, no. 1. e1593. https://doi.org/10.1038/cddis.2014.525
Dimri, G.P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E.E., Liskens, M., Rubelj, I., and Pereira-Smith, O., A biomarker that identifies senescent human cells in culture and in aging skin in vivo, Proc. Natl. Acad. Sci. U. S. A., 1995, vol. 92, p. 9363.
Ewald, J.A., Desotelle, J.A., Wilding, G., and Jarrard, D.F., Therapy-induced senescence in cancer, J. Natl. Cancer Inst., 2010, vol. 102, p. 1536.
Fan, Q.W., Cheng, C., Hackett, C., Feldman, M., Houseman, B.T., Nicolaides, T., Haas-Kogan, D., James, C.D., Oakes, S.A., Debnath, J., Shokat, K.M., and Weiss, W.A., Akt and autophagy cooperate to promote survival of drug-resistant glioma, Sci. Signal., 2010, vol. 3, p. ra81. https://doi.org/10.1126/scisignal.2001017
Fernández-Medarde, A. and Santos, E., Ras in cancer and developmental diseases, Genes Cancer, 2011, vol. 2, p. 344.
Ganley, IG, Lam, du, H, Wang, J, Ding, X, Chen, S, and Jiang, X., ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy, J. Biol. Chem., 2009, vol. 284, p. 12297.
Gordeev, S.A., Bykova, T.V., Zubova, S.G., Aksenov, N.D., and Pospelova, T.V., Antiapoptotic gene bcl-2 prevents cellular senescence program reactivation induced by histone deacetylase inhibitor sodium butyrate in E1A and cHa-ras transformed rat fibroblasts, Tsitologiya, 2015a, vol. 57, no. 2, p. 135.
Gordeev, S.A., Bykova, T.V., Zubova, S.G., Bystrova, O.A., Martynova, M.G., Pospelov, V.A., and Pospelova, T.V., mTOR kinase inhibitor pp242 causes mitophagy terminated by apoptotic cell death in E1A-Ras transformed cells, Oncotarget, 2015b, vol. 6, p. 44905.
Guo, J.Y., Chen, H., Mathew, R., Fan, J., Strohecker, A.M., Karsli-Uzunbas, G., Kamphorst, J.J., Chen, G., Lemons, J.M.S., Karantza, V., Coller, H.A., Dipaola, R.S., and Gelinas, C., et, al., Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis, Genes Dev., 2011, vol. 25, p. 460.
Hanahan, D. and Weinberg, R.A., Hallmarks of cancer: the next generation, Cell, 2011, vol. 144, p. 646.
Hernandez-Segura, A., Nehme, J., and Demaria, M., Hallmarks of cellular senescence, Trends Cell Biol., 2018, vol. 28, p. 436.
Hosokawa, N, Hara, T, Kaizuka, T, Kishi, C, Takamu-ra, A, Miura, Y, Iemura, S, Natsume, T, Takehana, K, Yamada, N, Guan, JL, Oshiro, N, and Mizushima, N., Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy, Mol. Biol. Cell, 2009, vol. 20, p. 1981.
Lampson, B.L. and Davids, M.S., The development and current use of BCL-2 inhibitors for the treatment of chronic lymphocytic leukemia, Curr. Hematol. Malig. Rep., 2017, vol. 12, p. 11.
Mariño, G., Pietrocola, F., Eisenberg, T., Kong, Y., Malik, S.A., Andryushkova, A., Schroeder, S., Pendl, T., Harger, A., Niso-Santano, M., Zamzami, N., Scoazec, M., Durand, S., Enot, D.P., Fernández, Á.F., et al., Regulation of autophagy by cytosolic acetyl-coenzyme A, Mol. Cell, 2014, vol. 53, p. 710.
Monick, M.M., Powers, L.S., Barrett, C.W., Hinde, S., Ashare, A., Groskreutz, D.J., Nyunoya, T., Coleman, M., Spitz, D.R., and Hunninghake, G.W., Constitutive ERK MAPK activity regulates macrophage ATP production and mitochondrial integrity, J. Immunol., 2008, vol. 180, p. 7485.
Niu, N., Li, Z., Zhu, M., Sun, H., Yang, J., Xu, S., Zhao, W., and Song, R., Effects of nuclear respiratory factor-1 on apoptosis and mitochondrial dysfunction induced by cobalt chloride in H9C2 cells, Mol. Med. Rep., 2019, vol. 19, p. 2153.
Porporato, P.E., Filigheddu, N., Bravo-San, Pedro, J.M., Kroemer, G., and Galluzzi, L., Mit. Metabol. Cancer. Cell Res., 2018, vol. 28, p. 265.
Quadir, M.A., Kwok, B., Dragowska, W.H., To, K.H., Le, D., Bally, M.B., and Gorski, S.M., Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization, Breast Cancer Res. Treat., 2008, vol. 112, p. 389.
Ryu, S.J., Oh, Y.S., and Park, S.C., Failure of stress-induced downregulation of Bcl-2 contributes to apoptosis resistance in senescent human diploid fibroblasts, Cell Death Differ., 2007, vol. 14, p. 1020.
Sarbassov, D.D., Ali, S.M., and Sabatini, D.M., Growing roles for the mTOR pathway, Curr. Opin. Cell Biol., 2005, vol. 17, p. 596.
Serrano, C., Romagosa, C., Hernández-Losa, J., Simonetti, S., Valverde, C., Moliné, T., Somoza, R., Pérez, M., Vélez, R., Vergés, R., Domínguez, R., Carles, J., and Ramón, Y, Cajal, S., RAS/MAPK pathway hyperactivation determines poor prognosis in undifferentiated pleomorphic sarcomas, Cancer, 2016, vol. 122, p. 99.
Toussaint, O., Medrano, E.E., and von Zglinicki, T., Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes, Exp. Gerontol., 2000, vol. 35, p. 927.
Trotta, A.P., Gelles, J.D., Serasinghe, M.N., Loi, P., Arbiser, J.L., and Chipuk, J.E., Disruption of mitochondrial electron transport chain function potentiates the pro-apoptotic effects of MAPK inhibition, J. Biol. Chem., 2017, vol. 292, p. 11727.
Viale, A., Pettazzoni, P., Lyssiotis, C.A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., Kost-Alimova, M., Muller, F., Colla, S., Nezi, L., Genovese, G., et al., Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function, Nature, 2014, vol. 514, p. 628.
Von Zglinicki, T, Saretzki, G, Ladhoff, J, d’Adda, di Fagagna, F, and Jackson, S., Human cell senescence as a DNA damage response, Mech. Ageing Dev., 2005, vol. 126, p. 111.
Wang, K. and Klionsky, D.J., Mitochondria removal by autophagy, Autophagy, 2011, vol. 7, p. 297.
Warburg, O., On the origin of cancer cells, Science, 1956a, vol. 123, p. 309.
Warburg, O., On respiratory impairment in cancer cells, Science, 1956b, vol. 124, p. 269.
Weinberg, F., Hamanaka, R., Wheaton, W.W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G.M., Budinger, G.R.S., and Chandel, N.S., Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity, Proc. Natl. Acad. Sci. U. S. A., 2010, vol. 107, p. 8788.
Funding
This work was supported by budgetary funding from the Institute of Cytology, Russian Academy of Sciences.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare that they have no conflict of interest. This article does not contain any studies involving animals or human participants performed by any of the authors.
Rights and permissions
About this article
Cite this article
Kochetkova, E.Y., Blinova, G.I., Boytsov, A.S. et al. Dependence of the Viability of Ras-Expressing Cells on Damage to Mitochondria Caused by Antitumor Agents. Cell Tiss. Biol. 14, 437–447 (2020). https://doi.org/10.1134/S1990519X20060061
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990519X20060061